Mark Shackleton

Professor Mark Shackleton is the director of medical oncology at Alfred Health and oversees the Monash Partners Comprehensive Cancer Consortium, which collaborates with Omico. He has been an advocate for integrating comprehensive genomic profiling into cancer treatment, emphasizing the need to make precision oncology advancements accessible to a broader population through existing health services.